Commissioner’s National Priority Voucher (CNPV) Pilot Program

changes
Press Release
View Article
Next Post
DemeRx Announces FDA Acceptance of IND Application to Advance DMX-1001 for the Treatment of Alcohol Use Disorder (AUD)
Previous Post
DemeRx Announces Successful Completion of Multiple Ascending Dose Clinical Trial of DMX-1001 for the Treatment of Alcohol Use Disorder (AUD)